미국의 치과용 골이식재 및 골대체재 시장 규모, 점유율, 동향 분석 보고서 : 소재별, 용도별, 최종 용도별, 부문별 예측(2026-2033년)

U.S. Dental Bone Grafts And Substitutes Market Summary

The U.S. dental bone grafts and substitutes market size was estimated at USD 272.96 million in 2025 and is projected to reach USD 613.31 million by 2033, growing at a CAGR of 10.82% from 2026 to 2033. The market growth is primarily driven by the rising adoption of dental implants and by increasing cases of periodontal disease, which lead to bone loss.

Growing awareness of advanced restorative procedures and the expanding elderly population further support demand for bone regeneration solutions. In addition, advancements in biomaterials and minimally invasive techniques are encouraging wider clinical adoption.

The increasing prevalence of periodontal disease is a significant driver of the U.S. dental bone grafts and substitutes industry. Advanced gum disease often leads to alveolar bone loss, creating the need for regenerative procedures to restore bone structure before implant placement. As more patients seek treatment for tooth loss caused by chronic periodontitis, demand for bone graft materials continues to rise. This growing clinical need supports the market's significant expansion.

The rising demand for cosmetic and restorative dentistry is driving significant growth in the U.S. dental bone grafts and substitutes market. Patients prefer long-lasting, natural-looking solutions such as implant-supported restorations over traditional dentures. Many of these procedures require bone augmentation to ensure implant stability and aesthetic outcomes. As a result, the growing focus on smile enhancement and functional restoration is driving higher utilization of dental bone graft materials.

For instance, Fountains Dental Care highlights that cosmetic dentistry continues to grow as patients seek naturally beautiful smiles and advanced restorative options such as implants, veneers, and bone regenerative procedures. This trend reflects greater interest in treatments that enhance aesthetics and improve oral function, often requiring supportive materials like dental bone grafts and substitutes. As dental practices adopt digital technologies and regenerative techniques to meet rising patient expectations, demand for related grafting solutions is also expanding.

U.S. Dental Bone Grafts And Substitutes Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. dental bone grafts and substitutes market report based on material type, application, and end-use:

• Material Type Outlook (Revenue, USD Million, 2021 - 2033)
• Autograft
• Allograft
  • Demineralized Bone Matrix
  • Others
• Xenograft
• Synthetic
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Ridge Augmentation
• Sinus Lift
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Socket Preservation
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Dental Clinics

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Material Type
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Estimates And Forecast Timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
  • 1.3.5. Details Of Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Price Analysis (Model 1)
  • 1.6.2. Approach 1: Commodity Flow Approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Dental Bone Grafts and Substitutes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising adoption of dental implants
    • 3.2.1.2. Increasing prevalence of periodontal disease
    • 3.2.1.3. Rising demand for cosmetic and restorative dentistry
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High procedure costs
    • 3.2.2.2. Limited insurance coverage
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Rising awareness about advanced dental treatments
    • 3.2.3.2. Development of synthetic and safer graft materials
    • 3.2.3.3. Increasing demand for minimally invasive and injectable grafts
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Risk of post-surgical complications
    • 3.2.4.2. Skilled professional requirement
    • 3.2.4.3. Variable regulatory requirements
• 3.3. U.S. Dental Bone Grafts and Substitutes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dental Bone Grafts and Substitutes Market: Material Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Dental Bone Grafts and Substitutes Market Material Type Movement Analysis
• 4.3. U.S. Dental Bone Grafts and Substitutes Market Size & Trend Analysis, by Material Type 2021 to 2033 (USD Million)
• 4.4. Autograft
  • 4.4.1. Autograft market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Allograft
  • 4.5.1. Allograft market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Demineralized bone matrix
    • 4.5.2.1. Demineralized bone matrix market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Others
    • 4.5.3.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Xenograft
  • 4.6.1. Xenograft market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Synthetic
  • 4.7.1. Synthetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Dental Bone Grafts and Substitutes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Dental Bone Grafts and Substitutes Market Application Movement Analysis
• 5.3. U.S. Dental Bone Grafts and Substitutes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Ridge Augmentation
  • 5.4.1. Ridge augmentation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Sinus Lift
  • 5.5.1. Sinus lift market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Periodontal Defect Regeneration
  • 5.6.1. Periodontal defect regeneration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Implant bone regeneration
  • 5.7.1. Implant bone regeneration market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.8. Socket Preservation
  • 5.8.1. Socket preservation market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Dental Bone Grafts and Substitutes Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Dental Bone Grafts and Substitutes Market End Use Movement Analysis
• 6.3. U.S. Dental Bone Grafts and Substitutes Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Dental Clinics
  • 6.5.1. Dental clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. Key company market share analysis, 2025
  • 7.3.2. Avtec Surgical
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Usage benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Dentsply Sirona
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Usage benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Geistlich Pharma
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Usage benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. BioHorizons
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Usage benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. ZimVie Inc.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Usage benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Institut Straumann AG
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Usage benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Osteogenics Biomedical
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Usage benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. botiss N.A. Inc (Straumann Group USA)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Usage benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Implant Direct Corporation
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Usage benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. DentiumUSA
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Usage benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. LifeNet Health
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Usage benchmarking
    • 7.3.12.4. Strategic initiatives